Y-mAbs Therapeutics, Inc. (YMAB)

NASDAQ: YMAB · Real-Time Price · USD

4.360

-0.160 (-3.54%)

At close: Jul 11, 2025, 4:00 PM

4.390

+0.030 (0.69%)

After-hours: Jul 11, 2025, 6:27 PM EDT

Y-mAbs Therapeutics Market Cap

Y-mAbs Therapeutics has a market cap or net worth of $197.49 million as of July 11, 2025. Its market cap has decreased by -63.23% in one year.

Market Cap

197.49M

Enterprise Value

137.78M

1-Year Change

-63.23%

Ranking

#3734

Market Cap Chart

Since September 21, 2018, Y-mAbs Therapeutics's market cap has decreased from $796.74M to $197.49M, a decrease of -75.21%. That is a compound annual growth rate of -18.53%.

Market Cap History

Date	Market Cap	% Change
Jul 11, 2025	197.49M	-43.69%
Dec 31, 2024	350.70M	17.88%
Dec 29, 2023	297.50M	39.61%
Dec 30, 2022	213.10M	-69.88%
Dec 31, 2021	707.47M	-64.73%
Dec 31, 2020	2.01B	61.56%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	711.91B
Johnson & Johnson	377.51B
AbbVie	339.94B
Novo Nordisk	305.41B
UnitedHealth Group	275.86B
Novartis AG	236.71B
Abbott Laboratories	229.69B
AstraZeneca	218.74B

Market Cap Rankings